Sign in

CIK 0001590750

  • Large accelerated filer

Viridian Therapeutics, Inc.\DE

Sign in to watch
Ticker
VRDN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
471187261
Phone
+1 617-272-4600
Business address
221 CRESCENT STREET, SUITE 103A, WALTHAM, MA, 02453
Former names
MIRAGEN THERAPEUTICS, INC., SIGNAL GENETICS, INC., SIGNAL GENETICS LLC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$348,194
in 1 filing

Net −$348,194. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Tousignant Jennifer −$348K Chief Legal Officer sold 100% of stake

Reading 15 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-07-01 Moses Jennifer K. Director Grant or award · Stock Option (Right to Buy) +32,341 32,341
2025-07-01 Moses Jennifer K. Director Grant or award · Stock Option (Right to Buy) +21,000 21,000
2024-06-26 Moses Jennifer K. Director Grant or award · Stock Option (Right to Buy) +21,000 21,000
2023-06-14 Moses Jennifer K. Director Grant or award · Stock Option (Right to Buy) +20,000 20,000
2022-06-08 Moses Jennifer K. Director Grant or award · Stock Option (Right to Buy) +12,500 12,500
2021-07-14 Moses Jennifer K. Director Grant or award · Stock Option (Right to Buy) +25,000 25,000

Page 1 of 1 · 6 trades